[HTML][HTML] Liver injury in COVID-19 patients with drugs as causatives: a systematic review of 996 DILI cases published 2020/2021 based on RUCAM as causality …
R Teschke, N Méndez-Sánchez, A Eickhoff - International journal of …, 2022 - mdpi.com
Patients with coronavirus disease 19 (COVID-19) commonly show abnormalities of liver
tests (LTs) of undetermined cause. Considering drugs as tentative culprits, the current …
tests (LTs) of undetermined cause. Considering drugs as tentative culprits, the current …
[HTML][HTML] Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), accountable for causing
the coronavirus diseases 2019 (COVID-19), is already declared as a pandemic disease …
the coronavirus diseases 2019 (COVID-19), is already declared as a pandemic disease …
[HTML][HTML] Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines
N Aghamohamadi, F Shahba… - Frontiers in …, 2023 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is potentially pathogenic
and causes severe symptoms; in addition to respiratory syndromes, patients might …
and causes severe symptoms; in addition to respiratory syndromes, patients might …
[HTML][HTML] The des-Arg9-bradykinin/B1R axis: Hepatic damage in COVID-19
GMM Mendes, IJB Do Nascimento… - Frontiers in …, 2022 - frontiersin.org
Patients infected by the SARS-CoV-2 virus are commonly diagnosed with threatening liver
conditions associated with drug-induced therapies and systemic viral action. RNA-Seq data …
conditions associated with drug-induced therapies and systemic viral action. RNA-Seq data …
[HTML][HTML] Management of hepatitis B virus reactivation due to treatment of COVID-19
The world has made significant progress in developing novel treatments for COVID-19 since
the pandemic began. Some treatments target the patient's dysregulated inflammatory …
the pandemic began. Some treatments target the patient's dysregulated inflammatory …
Layer-by-layer reinforced-mediated sustained-release nanoantioxidants for long-lasting prevention against drug-induced liver injury
P Tang, H Wu, M Wang, Y Wang, R Zhang… - Colloids and Surfaces B …, 2023 - Elsevier
Drug-induced liver injury (DILI) is a commonly encountered and diagnostically complex
etiology of acute liver failure, characterized by early indications of hepatic oxidative stress …
etiology of acute liver failure, characterized by early indications of hepatic oxidative stress …
[HTML][HTML] The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome
LM Naseralallah, BA Aboujabal, NM Geryo… - PLoS …, 2022 - journals.plos.org
Background Drug induced liver injury (DILI) is a rising morbidity amongst patients with
COVID-19 clinical syndrome. The updated RUCAM causality assessment scale is validated …
COVID-19 clinical syndrome. The updated RUCAM causality assessment scale is validated …
[HTML][HTML] Gastrointestinal imaging findings in the era of COVID-19: a pictorial review
X Mavropoulou, E Psoma, A Papachristodoulou… - Medicina, 2023 - mdpi.com
The potentially fatal COVID-19 pandemic has been associated with a largespectrum of
clinical presentations. Beyond the classical pulmonary manifestations, gastrointestinal tract …
clinical presentations. Beyond the classical pulmonary manifestations, gastrointestinal tract …
[HTML][HTML] Hepatic, extrahepatic and extracellular vesicle cytochrome p450 2e1 in alcohol and acetaminophen-mediated adverse interactions and potential treatment …
Alcohol and several therapeutic drugs, including acetaminophen, are metabolized by
cytochrome P450 2E1 (CYP2E1) into toxic compounds. At low levels, these compounds are …
cytochrome P450 2E1 (CYP2E1) into toxic compounds. At low levels, these compounds are …
[HTML][HTML] Pathogenetic mechanisms of liver-associated injuries, management, and current challenges in COVID-19 patients
The global outbreak of COVID-19 possesses serious challenges and adverse impacts for
patients with progression of chronic liver disease and has become a major threat to public …
patients with progression of chronic liver disease and has become a major threat to public …